Cargando…

Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma

[Image: see text] Patients with pancreatic ductal adenocarcinoma (PDAC) have a dismal 5 year survival of 9%. One important limiting factor for treatment efficacy is the dense tumor-supporting stroma. The cancer-associated fibroblasts in this stroma deposit excessive amounts of extracellular matrix c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorst, Daphne N., Smeets, Esther M. M., Klein, Christian, Frielink, Cathelijne, Geijs, Daan, Trajkovic-Arsic, Marija, Cheung, Phyllis F. Y., Stommel, Martijn W. J., Gotthardt, Martin, Siveke, Jens T., Aarntzen, Erik H. J. G., van Lith, Sanne A. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410663/ https://www.ncbi.nlm.nih.gov/pubmed/37485886 http://dx.doi.org/10.1021/acs.molpharmaceut.3c00453

Ejemplares similares

Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy
por: Smeets, Esther M. M., et al.
Publicado: (2023)

Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
por: Boss, Marti, et al.
Publicado: (2020)

Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis
por: Dorst, Daphne N, et al.
Publicado: (2020)

CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody
por: Collado Camps, Estel, et al.
Publicado: (2021)

Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin(9-39)
por: Collado Camps, Estel, et al.
Publicado: (2022)

Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy
por: Dorst, Daphne N, et al.
Publicado: (2021)

Fibroblast Activation Protein Targeted Photodynamic Therapy Selectively Kills Activated Skin Fibroblasts from Systemic Sclerosis Patients and Prevents Tissue Contraction
por: Dorst, Daphne N., et al.
Publicado: (2021)

Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma
por: Heid, Irina, et al.
Publicado: (2022)

X-Ray Phase-Contrast CT of a Pancreatic Ductal Adenocarcinoma Mouse Model
por: Tapfer, Arne, et al.
Publicado: (2013)

Targeted Optical Imaging of the Glucagonlike Peptide 1 Receptor Using Exendin-4-IRDye 800CW
por: Boss, Marti, et al.
Publicado: (2020)

(111)In-exendin Uptake in the Pancreas Correlates With the β-Cell Mass and Not With the α-Cell Mass
por: Brom, Maarten, et al.
Publicado: (2015)

Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene
por: Schmohl, Kathrin A., et al.
Publicado: (2017)

Native glycan fragments detected by MALDI mass spectrometry imaging are independent prognostic factors in pancreatic ductal adenocarcinoma
por: Sun, Na, et al.
Publicado: (2021)

Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors
por: Lütje, Susanne, et al.
Publicado: (2019)

Apparent Diffusion Coefficient (ADC) predicts therapy response in pancreatic ductal adenocarcinoma
por: Trajkovic-Arsic, M., et al.
Publicado: (2017)

New Radiolabeled Exendin Analogues Show Reduced Renal Retention
por: Joosten, Lieke, et al.
Publicado: (2023)

Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin
por: Eter, Wael A., et al.
Publicado: (2015)

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
por: Zhang, Tianyi, et al.
Publicado: (2022)

Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma
por: Kawase, Tomoya, et al.
Publicado: (2015)

Is metabolism the magic bullet for targeted cancer therapy?
por: Trajkovic-Arsic, Marija, et al.
Publicado: (2023)

Optimal respiratory-gated [(18)F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma
por: Smeets, Esther M. M., et al.
Publicado: (2019)

Site-Specific Dual-Labeling of a VHH with a Chelator and a Photosensitizer for Nuclear Imaging and Targeted Photodynamic Therapy of EGFR-Positive Tumors
por: Renard, Emma, et al.
Publicado: (2021)

Fibroblasts as a Biological Marker for Curative Resection in Pancreatic Ductal Adenocarcinoma
por: Katsuta, Eriko, et al.
Publicado: (2020)

SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for β-cell mass assessments
por: Eter, Wael A., et al.
Publicado: (2016)

Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma
por: Croft, Wayne, et al.
Publicado: (2023)

Cancer-Associated Fibroblasts’ Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma
por: Awaji, Mohammad, et al.
Publicado: (2019)

Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
por: Derks, Yvonne H. W., et al.
Publicado: (2023)

Self-Assembling VHH-Elastin-Like Peptides for Photodynamic Nanomedicine
por: Pille, Jan, et al.
Publicado: (2017)

Genetic ablation of Smoothened in pancreatic fibroblasts increases acinar–ductal metaplasia
por: Liu, Xin, et al.
Publicado: (2016)

Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma
por: Lintern, Nicole, et al.
Publicado: (2023)

5-Aminolaevulinic Acid-Based Photodynamic Therapy Restrains Pathological Hyperplasia of Fibroblasts
por: Wang, Xiaochuan, et al.
Publicado: (2017)

Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
por: Karimnia, Vida, et al.
Publicado: (2021)

Photodynamic Therapy Targeting Macrophages Using IRDye700DX-Liposomes Decreases Experimental Arthritis Development
por: Dorst, Daphne N., et al.
Publicado: (2021)

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting
por: Vaish, Utpreksha, et al.
Publicado: (2021)

Multiphasic Heterogeneity of Fibroblasts in the Microenvironment of Pancreatic Ductal Adenocarcinoma: Dissection and the Sum of the Dynamics
por: Ijichi, Hideaki
Publicado: (2022)

Understanding and Targeting Natural Killer Cell-Cancer-Associated Fibroblast Interactions in Pancreatic Ductal Adenocarcinoma
por: Malchiodi, Zoe X., et al.
Publicado: (2021)

Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
por: Neuzillet, Cindy, et al.
Publicado: (2019)

Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies
por: Privé, Bastiaan M., et al.
Publicado: (2023)

Significance of Basic Fibroblast Growth Factor and Fibroblast Growth Factor Receptor Protein Expression in the Formation of Fibrotic Focus in Invasive Ductal Carcinoma of the Breast
por: Hasebe, Takahiro, et al.
Publicado: (1997)

MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
por: Kadera, Brian E., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7ec8l8g9n8cglaakmlgn0pemgg